Healthtech Startups

Janux Therapeutics is a clinical-stage biotech company developing precision-engineered immunotherapies for the treatment of cancer and autoimmune diseases. It uses its TRACTr, TRACIr, and ARM platforms to engineer drug candidates intended to direct the immune system against disease while limiting systemic safety issues.

3 investors

Jeisys is a company focused on aesthetic and medical treatment products, presenting itself as a global provider open to partnerships and product inquiries. The page provides limited concrete detail beyond a focus on treatment-related offerings and worldwide connections.

3 investors

JNPMEDI is a South Korean company that builds medical data platforms using blockchain and cloud technology, including a clinical trial data management solution. It serves clinical trial and healthcare clients, and in 2024 expanded into professional services applying digital technology across clients' business processes.

3 investors

Jolt is a SmartSense Solution that provides IoT-enabled digital employee empowerment tools including digital checklists, self-training modules, and real-time communication platforms designed for multi-site operations management in industries like food service and healthcare.

3 investors

Journey Health is a healthcare company that delivers digital health services and support for vulnerable patients and underserved communities. It combines clinical expertise with digital tools to provide accessible, community-centered care.

3 investors

Joyce provides nutrition care through dietitians and daily food coaches, connecting doctors' dietary orders with patients' everyday eating and offering ongoing support between clinic visits. It serves patients as well as healthcare providers seeking better outcomes.

3 investors

Joyful Health builds an AI-powered financial operating system for healthcare providers that specializes in revenue cycle management, specifically handling claim denials and aged claims follow-up. The platform helps clinicians and healthcare teams automate revenue operations to reduce administrative burden.

3 investors

JOYMODE produces dietary supplements targeting male sexual health and wellness. IGNITE is a libido-boosting capsule formulated with natural ingredients like Mucuna Pruriens, Saffron, and Shilajit to support dopamine, sexual motivation, and arousal.

3 investors

Jupiter Endovascular develops the Vertex Pulmonary Embolectomy System, a catheter-based device with Transforming Fixation technology for treating pulmonary embolism and other cardiovascular conditions. The company serves interventional cardiologists and healthcare institutions treating underserved cardiac patient populations.

3 investors

A biopharmaceutical company developing CAR-T cell therapies for cancer treatment. The company produces Benastim (瑞基奥仑赛注射液), a CAR-T therapeutic approved by China's National Medical Products Administration.

3 investors

A biotechnology company developing cancer therapies for patients with unmet medical needs. Its clinical pipeline includes the KTX-1001 and KTX-2001 programs.

3 investors

Kabilah provides an AI-powered platform for inpatient nursing workflows that automates verbal handoffs, generates digital report sheets, and integrates with EHR systems to reduce documentation burden. The solution is designed for hospital nursing teams to improve patient safety and operational efficiency.

3 investors

Kairon Health offers a data platform for value-based care that ingests claims, clinical records, and qualitative data to run healthcare workflows including field team prep, care management, HCC coding, quality gap closure, and patient outreach. It serves provider organizations and their practices with tools for practice enablement, care operations, AI-driven patient activation, and impact analytics tied to billed visits.

3 investors

Kalium Health is developing personalised, at-home health monitoring for chronic kidney disease, aimed at helping healthcare providers and patients track key risks to improve outcomes and reduce costs. It targets value-based care providers and the shift of kidney care into the home.

3 investors

KalVista Pharmaceuticals is a global biopharmaceutical company that develops oral therapies for rare diseases, starting with hereditary angioedema (HAE). Its pipeline includes preclinical oral Factor XIIa inhibitors targeting HAE prophylaxis as well as thrombosis and inflammation.

3 investors

Karavela builds a foundation model of the human brain using magnetic resonance imaging and develops AI tools to enhance clinical trials in psychiatry and neurology. The company collects large-scale high-quality brain activity datasets from healthy participants to support personalized treatment research.

3 investors

Kardium develops the Globe Pulsed Field System, an all-in-one cardiac ablation catheter with 122 individually selectable electrodes that combines high-density mapping and pulsed field ablation. It is designed for physicians treating patients with atrial fibrillation.

3 investors

KarunaHOME delivers a 12-week at-home program combining AI technology, neuroscience-based coaching, and personalized rehabilitation to help patients with chronic pain reduce symptoms and medication use. The program serves individuals suffering from various chronic pain conditions through a combination of proprietary device technology, certified coaching, and digital educational content.

3 investors

Karyopharm is a pharmaceutical company developing drugs based on its SINE (Selective Inhibitor of Nuclear Export) technology, with medicines targeting cancers including multiple myeloma and diffuse large B-cell lymphoma. It serves patients and healthcare providers in oncology.

3 investors

Katalyze builds AI agents and a Primary Production Record that unify process data across batches, sites, and instruments to surface the signals affecting yield and quality, returning each with supporting evidence for expert review. It targets industrial and biopharma/manufacturing production teams to improve commercial yield, plant throughput, and reduce deviation investigations.

3 investors

Kayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology. The company is led by an experienced management team supported by scientific and clinical advisory boards.

3 investors

Keleya provides pregnancy and postpartum digital health applications offering personalized expert guidance, fitness content, and birth preparation courses for pregnant women and new mothers. Many German health insurance providers cover the premium subscription and birth preparation course.

3 investors

Keona Health offers CareDesk, an AI-assisted patient access platform that handles voice, chat, and web requests for medical practices, automating scheduling, refills, reminders, and cancellations while routing complex calls to staff with full patient context. It integrates with EHR systems like Epic, Cerner, and athenahealth and serves healthcare providers and call centers.

3 investors

Kindara provides a digital fertility charting app and community that helps users track their fertility, understand their body, or use fertility awareness-based contraception methods.

3 investors